Atrial Fibrillation Also called: AF, AFib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effects of PAP on Afib Recurrence Risk After Catheter Ablation in OSA Patients

Conditions:   Obstructive Sleep Apnea;   Atrial Fibrillation
Intervention:   Procedure: Cardiac Ablation for Atrial Fibrillation
Sponsor:   Stanford University
Recruiting

Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation

Conditions:   Paroxysmal Atrial Fibrillation;   Atrial Arrhythmia
Interventions:   Procedure: Circumferential Pulmonary Vein Ablation;   Procedure: Segmental Pulmonary Vein Isolation
Sponsor:   University of California, San Diego
Active, not recruiting

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: Insertable Cardiac Monitor
Sponsors:   University of Rochester;   Biotronik, Inc.
Not yet recruiting

Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

Condition:   Atrial Fibrillation
Interventions:   Device: renal denervation;   Device: Catheter ablation
Sponsor:   Vivek Reddy
Not yet recruiting

Half-normal Saline in Atrial Fibrillation Ablation

Condition:   Atrial Fibrillation
Interventions:   Drug: Half-normal saline;   Drug: Normal saline
Sponsor:   Texas Cardiac Arrhythmia Research Foundation
Recruiting

Mapping Electrogram Morphology Recurrence for Atrial Fibrillation Ablation

Condition:   Atrial Fibrillation
Intervention:   Device: Electrogram Morphology Mapping (EMR)
Sponsors:   Jeffrey Goldberger;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Liraglutide Effect in Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: Liraglutide;   Other: RFM;   Drug: Anti Arrhythmics;   Procedure: Afib Catheter Ablation
Sponsor:   University of Miami
Recruiting

Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Device: Radiofrequency Ablation
Sponsor:   Biosense Webster, Inc.
Recruiting

Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation

Conditions:   Cardiovascular Diseases;   Atrial Fibrillation, Persistent
Interventions:   Procedure: Isolation of pulmonary veins;   Procedure: Ablation by radiofrequency of low-voltage areas
Sponsor:   French Cardiology Society
Recruiting

FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   University of Miami
Recruiting

The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms

Conditions:   Atrial Fibrillation;   Type 2 Diabetes
Intervention:   Behavioral: High-intensity interval training + standard care
Sponsor:   Ottawa Heart Institute Research Corporation
Not yet recruiting

Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation

Condition:   Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases
Interventions:   Device: cryoballoon ablation system;   Drug: Antiarrhythmic Drugs
Sponsors:   Medtronic Cardiac Rhythm and Heart Failure;   Medtronic Atrial Fibrillation Solutions
Active, not recruiting

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, Bay59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Completed

The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study

Conditions:   Atrial Fibrillation;   Alcohol
Interventions:   Drug: Ethanol;   Drug: Placebo
Sponsor:   University of California, San Francisco
Active, not recruiting

Effects of Topical Local Anesthesia of Pulmonary Vein Combined With Vagus Nerve Block on the Incidence of Atrial Fibrillation After Thoracic Surgery

Condition:   Atrial Fibrillation
Intervention:   Procedure: topical local anesthesia of pulmonary vein combined with vagus nerve block
Sponsor:   Han Yuan
Recruiting

Rate Control in Atrial Fibrillation II

Conditions:   Atrial Fibrillation;   Permanent Atrial Fibrillation
Interventions:   Drug: Metoprolol;   Drug: Diltiazem
Sponsors:   Asker & Baerum Hospital;   Vestre Viken Hospital Trust;   Helse Sor-Ost
Recruiting

iCLAS™ for Persistent Atrial Fibrillation

Condition:   Persistent Atrial Fibrillation
Intervention:   Device: Adagio AF Cryoablation System (iCLAS™)
Sponsor:   Adagio Medical
Recruiting

Esophageal Deviation in Atrial Fibrillation Ablation

Condition:   Atrial Fibrillation
Intervention:   Device: DV8
Sponsor:   Massachusetts General Hospital
Recruiting

Does the Merged 3D Imaging Improve Contact Force and Long Term Procedure Outcome in Atrial Fibrillation?

Condition:   Atrial Fibrillation
Interventions:   Procedure: FAM 3D map group;   Procedure: FAM-CT 3D map group
Sponsors:   Korea University Guro Hospital;   Johnson & Johnson
Completed

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin sodium
Sponsors:   Bayer;   Janssen Research & Development, LLC
Completed

Impact of Peri-Atrial Inflammatory Fat Tissue on Atrial Fibrillation Using Ultra-High Resolution CT

Condition:   Atrial Fibrillation
Intervention:   Procedure: Catheter ablation
Sponsor:   Johns Hopkins University
Not yet recruiting

Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrillation Patients (CAAN-AF)

Conditions:   Heart Failure;   Atrial Fibrillation
Interventions:   Procedure: AV nodal ablation;   Drug: Medical Ventricular Rate Control
Sponsors:   University of Adelaide;   Medtronic;   Abbott Medical Devices;   Boston Scientific Corporation
Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Conditions:   Atrial Fibrillation;   Stroke;   Bleeding
Interventions:   Drug: Antiplatelet-only strategy;   Drug: Oral Anticoagulant plus background antiplatelet therapy
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Heart, Lung, and Blood Institute (NHLBI);   Vanderbilt University Medical Center
Not yet recruiting

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Condition:   Non-valvular Atrial Fibrillation (NVAF)
Intervention:   Drug: Rivaroxaban(Xarelto,BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving HemoDialysis

Conditions:   Atrial Fibrillation;   End Stage Renal Failure on Dialysis
Interventions:   Drug: Warfarin;   Drug: Apixaban;   Other: No oral anticoagulation
Sponsors:   St. Michael's Hospital, Toronto;   Canadian Institutes of Health Research (CIHR)
Recruiting

Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Coronary Heart Disease
Intervention:  
Sponsor:   Henan Institute of Cardiovascular Epidemiology
Recruiting

The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention

Conditions:   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: Rivaroxaban
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting

Dabigatran for Mitral Stenosis Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Mitral Stenosis
Interventions:   Drug: Dabigatran etexilate;   Drug: Warfarin
Sponsor:   The University of Hong Kong
Not yet recruiting

Effect of Treatment of Sleep Apnea in Patients With Paroxysmal Atrial Fibrillation

Conditions:   Sleep Disordered Breathing;   Sleep Apnea;   Paroxysmal Atrial Fibrillation
Intervention:   Device: PAP (CPAP or ASV)
Sponsors:   Oslo University Hospital;   Norwegian Health Association;   Medtronic;   ResMed
Active, not recruiting

Treatment Success With the CoolLoop Cryoablation System

Conditions:   Atrial Fibrillation;   Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation;   Arrhythmias, Cardiac;   Cardiovascular Diseases;   Heart Diseases
Intervention:   Device: CoolLoop® cryoablation system
Sponsors:   AFreeze GmbH;   Raffeiner GmbH
Recruiting

Perioperative Anticoagulant Use for Surgery Evaluation Study Part 2 Pilot

Condition:   Atrial Fibrillation
Interventions:   Other: PAUSE Perioperative DOAC Management;   Other: ASRA Perioperative DOAC Management
Sponsors:   McMaster University;   Hamilton Health Sciences Corporation;   St. Joseph's Healthcare Hamilton
Not yet recruiting

Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study

Condition:   AF - Atrial Fibrillation
Intervention:   Other: Observational
Sponsor:   Ain Shams University
Completed

Combining Left Atrial Appendage Closure With Cryoballoon Ablation in Chinese Population

Condition:   Atrial Fibrillation
Intervention:   Combination Product: cryoballoon ablation combining with left atrial appendage closure
Sponsor:   Shanghai 10th People's Hospital
Recruiting

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

Conditions:   Atrial Fibrillation;   Valve Heart Disease
Interventions:   Drug: Dabigatran;   Drug: Acetylsalicylic acid;   Drug: Warfarin
Sponsors:   Asan Medical Center;   Boehringer Ingelheim
Active, not recruiting

Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)

Conditions:   Atrial Fibrillation;   Recurrence
Interventions:   Drug: Colchicine 0.6 mg;   Drug: Matching placebo
Sponsor:   Population Health Research Institute
Not yet recruiting

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial

Condition:   Ischaemic Stroke
Interventions:   Drug: Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®);   Drug: Late treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)
Sponsor:   University Hospital Inselspital, Berne
Recruiting

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

Condition:   Atrial Fibrillation
Interventions:   Drug: warfarin;   Drug: apixaban
Sponsor:   Pfizer
Active, not recruiting

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

Condition:   Atrial Fibrillation
Intervention:   Drug: Non-vitamin K antagonist oral anticoagulant
Sponsor:   Boehringer Ingelheim
Recruiting

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Conditions:   Atrial Fibrillation;   Atrial Appendage;   Hemorrhage
Interventions:   Drug: Rivaroxaban 10 mg qd;   Drug: Rivaroxaban 15 mg qd;   Drug: DAPT
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Action Research Group;   Bayer
Completed

Japanese Pradaxa PMS, Long Term

Condition:   Atrial Fibrillation
Intervention:   Drug: Prazaxa Capsules
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Individualized Approach vs. Fixed Approach

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Procedure: Catheter ablation
Sponsor:   University of Luebeck
Recruiting

OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial

Conditions:   Stroke, Acute;   Atrial Fibrillation
Intervention:   Drug: Direct oral anticoagulant (DOAC)
Sponsor:   University College, London
Recruiting

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Condition:   Atrial Fibrillation
Intervention:   Device: Medtronic Pulsed Field Ablation (PFA) System
Sponsor:   Medtronic Cardiac Rhythm and Heart Failure
Not yet recruiting

FIRE AND ICE II Trial Pilot

Conditions:   Persistent Atrial Fibrillation;   Atrial Arrhythmia
Interventions:   Device: Cryoballoon (Arctic Front Advance Cryoballoon);   Device: Radiofrequency Catheter (ThermoCool Smarttouch)
Sponsors:   Medtronic Cardiac Rhythm and Heart Failure;   genae associates (CRO), Antwerp, Belgium;   King's College London;   Deutsches Herzzentrum Muenchen
Recruiting

Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

Condition:   Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk
Interventions:   Drug: Bivalirudin;   Drug: Heparin
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting

Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O

Condition:   Atrial Fibrillation (AF)
Interventions:   Diagnostic Test: multipolar mapping catheter;   Diagnostic Test: multielectrode circular catheter;   Diagnostic Test: irrigated ablation catheter
Sponsors:   University Hospital, Basel, Switzerland;   Boston Scientific Corporation
Recruiting

The Conformal Prague Study

Condition:   Non-valvular Atrial Fibrillation
Intervention:   Device: Left Atrial Appendage Closure
Sponsor:   Conformal Medical, Inc
Recruiting

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Condition:   Atrial Fibrillation
Intervention:   Drug: Idarucizumab
Sponsor:   Boehringer Ingelheim
Recruiting

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

Condition:   Stroke
Interventions:   Device: Coherex WaveCrest® Left Atrial Appendage Occlusion System;   Device: Watchman® LAA Closure Device
Sponsors:   Coherex Medical;   Biosense Webster, Inc.
Active, not recruiting

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

Conditions:   Atrial Fibrillation;   Atrial Flutter
Interventions:   Drug: Propofol;   Drug: Methohexital
Sponsor:   Wake Forest University Health Sciences
Not yet recruiting

A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers

Conditions:   Atrial Fibrillation;   Venous Thromboembolism
Interventions:   Drug: RABEprazole 20 Mg Oral Delayed Release Tablet;   Drug: APO-Dabigatran 150mg
Sponsors:   Population Health Research Institute;   Hamilton Health Sciences Corporation
Not yet recruiting

Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms

Condition:   Myeloproliferative Neoplasm
Intervention:   Drug: DOACs
Sponsor:   Fondazione per la Ricerca Ospedale Maggiore
Recruiting

Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data

Condition:   Renal Function
Intervention:   Other: No Intervention
Sponsor:   Bayer
Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Active, not recruiting

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Conditions:   Atrial Fibrillation;   Venous Thromboembolism;   Arterial Vascular Disease
Intervention:  
Sponsors:   McMaster University;   Hamilton Health Sciences Corporation;   St. Joseph's Healthcare Hamilton
Recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin;   Drug: Antiplatelet drugs
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting

Remote ECG Monitoring of TAVI Patients

Conditions:   Cardiac Valve Disease;   Aortic Valve Stenosis
Intervention:   Device: mobile Cardiac Arrhythmia Diagnostics Service (m-CARDS)
Sponsors:   Population Health Research Institute;   Hamilton Health Sciences Corporation;   Southlake Regional Health Centre;   Sunnybrook Health Sciences Centre;   M-Health Solutions
Recruiting

I Can sEe Left Atrial Appendage (ICELAA) Clinical Study

Conditions:   Efficacy, Self;   Safety Issues
Intervention:   Device: intra-procedural intracardiac echocardiography
Sponsor:   Boston Scientific Corporation
Not yet recruiting

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

Conditions:   Venous Thromboembolism;   Menstruation
Interventions:   Drug: Apixaban;   Drug: Rivaroxaban
Sponsor:   Indiana University
Recruiting

BIO|STREAM.ICM Obesity

Conditions:   Tachycardia Atrial;   Atrial Fibrillation;   Syncope;   Bradycardia;   Cryptogenic Stroke
Intervention:  
Sponsor:   Biotronik SE & Co. KG
Not yet recruiting

Multiple Chronic Conditions for Older Adults

Condition:   Chronic Disease
Interventions:   Other: Treatment as usual (TAU) + Internet;   Behavioral: TAU + ElderTree
Sponsors:   University of Wisconsin, Madison;   University of Wisconsin Hospital and Clinics (UW Health);   Medical University of South Carolina;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

Conditions:   Pancreas Cancer;   DVT;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Thomas Jefferson University
Not yet recruiting

Apple Heart & Movement Study

Condition:   Prevention
Intervention:   Diagnostic Test: Predictors of events
Sponsors:   Brigham and Women's Hospital;   Apple Inc.;   American Heart Association
Recruiting

Phrenic Nerve Injury During Pulmonary Vein Isolation With the Second-generation Cryoballoon.

Condition:   Phrenic Nerve Palsy
Intervention:  
Sponsors:   University of Luebeck;   Principal Investigator: Roland Richard Tilz, MD
Completed

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk CLL

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Drug: ACP-196;   Drug: ibrutinib
Sponsor:   Acerta Pharma BV
Active, not recruiting

Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population

Conditions:   Acute Myocardial Infarction;   Non-Obstructive Coronary Atherosclerosis;   Ischemic Heart Disease;   Angina Pectoris;   Coronary Microvascular Disease
Interventions:   Other: MINOCA registry;   Diagnostic Test: CCTA Phenotypes
Sponsor:   AHEPA University Hospital
Not yet recruiting

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.

Conditions:   Postpartum Hemorrhage;   Twin
Intervention:   Drug: Carbetocin
Sponsor:   Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Not yet recruiting

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

Conditions:   Frail Elderly;   Coronary Artery Disease
Interventions:   Procedure: Off-pump coronary-artery bypass grafting;   Procedure: On-pump coronary-artery bypass grafting
Sponsors:   University of Sao Paulo General Hospital;   Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo;   Hospital Alberto Urquiza Wanderley;   Hospital das Clínicas Samuel Libânio;   Hospital Samaritano Paulista;   Beneficência Portuguesa de São Paulo;   Hospital Samaritano Campinas;   Instituto Nacional de Cardiologia de Laranjeiras;   Pronto-Socorro Cardiológico Universitário de Pernambuco;   Mount Sinai Hospital, New York
Recruiting

Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease

Condition:   Diabetic Kidney Disease
Interventions:   Drug: SEL;   Drug: Placebo
Sponsor:   Gilead Sciences
Recruiting

Mid-Q Response Study

Conditions:   Heart Failure;   Left Bundle-Branch Block;   Heart Failure With Reduced Ejection Fraction (HFrEF);   Heart Failure NYHA Class II;   Heart Failure NYHA Class III;   Heart Failure NYHA Class IV
Interventions:   Device: aCRT ON;   Device: aCRT OFF
Sponsors:   Medtronic Bakken Research Center;   Medtronic;   Medtronic Japan Co., Ltd.
Not yet recruiting

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Conditions:   Influenza;   Pneumonia;   Lower Respiratory Tract Infection;   Acute Myocardial Infarction;   Congestive Heart Failure;   Stroke
Interventions:   Biological: Flublok Quadrivalent;   Biological: Standard Dose Inactivated Influenza Vaccine (SD-IIV)
Sponsors:   Kaiser Permanente;   Sanofi Pasteur, a Sanofi Company
Recruiting

The Artificial Kidney Initiation in Kidney Injury 2

Condition:   Renal Replacement Therapy for Acute Kidney Injury in ICU
Interventions:   Procedure: Standard strategy;   Procedure: Delayed strategy
Sponsor:   Assistance Publique - Hôpitaux de Paris
Active, not recruiting

Financial Incentives, Randomization With Stepped Treatment Trial

Condition:   Unhealthy Alcohol Use
Interventions:   Behavioral: Contingency Management Counseling;   Behavioral: Addiction Physician Management;   Behavioral: Motivational Enhancement Therapy
Sponsors:   Yale University;   VA Connecticut Healthcare System;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting